DANIEL K. SPIEGELMAN - 27 May 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: Daniel K. Spiegelman
Issuer symbol
MYGN
Transactions as of
27 May 2021
Transactions value $
$0
Form type
4
Filing time
28 May 2021, 18:48:14 UTC
Previous filing
21 May 2021
Next filing
01 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Disposed to Issuer $0 -15,889 -43.6% $0.000000 20,562 27 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 27, 2021, the Company rescinded Mr. Spiegelman's grant of 15,889 restricted stock units granted on December 4, 2020 and reported on the Form 4 filed with the Securities and Exchange Commission on December 7, 2020.